Concourse Financial Group Securities, Inc. Benitec Biopharma Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share
Q2 2023 Aug 10, 2023	BUY	$0.19 - $0.36 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.18 - $0.36 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.13 - $5.95 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.31 - $6.32 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.74 - $2.29 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.96 - $2.96 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.62 - $3.77 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.49 - $4.26 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$3.94 - $5.81 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.59 - $9.26 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$2.61 - $4.79 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$5.66 - $8.7 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$5.13 - $14.17 $0 - $0

Others Institutions Holding BNTC

# of Institutions

Shares Held

797K

Call Options Held

Put Options Held

View Full List

About Benitec Biopharma Inc.

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $299M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

More about BNTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account